IMNN

0.53555.22%
JE

James E. Dentzer

Independent Director

Mr. James E. Dentzer, also known as Jim, serves as Independent Director of Imunon, Inc. since September 2022. He serves as President, Chief Executive Officer & Director since September 24, 2018 and Secretary & Treasurer since September 2018 at Curis, Inc. Mr. Dentzer served as Treasurer since September 24, 2018 till March 2019 and also served as Secretary since March 2016 until March 2019 at Curis, Inc. Mr. Dentzer served as Chief Financial Officer and Chief Administrative Officer of Curis, Inc. since March 30, 2016 to March 2018 and its Chief Operating Officer since March 21, 2018 to September 2018. Mr. Dentzer joined the Curis, Inc. on March 30, 2016. Mr. Dentzer served as the Chief Financial Officer of Dicerna Pharmaceuticals, Inc. from December 2013 to December 18, 2015. He served as the Chief Financial Officer of Valeritas, Inc. since March 2010 to December 2013. Mr. Dentzer served as Chief Financial Officer of Amicus Therapeutics, Inc. from October 2, 2006 to October 30, 2009 and served its Principal Accounting Officer. He joined Amicus from Biogen Idec Inc., where he served as Vice President and Corporate Controller from November 2003 to October 2006. Prior to joining Biogen Idec, he served in a variety of financial positions at E. I. Du Pont de Nemours and Company, including Chief Financial Officer of DuPont Flooring Systems. Prior to Biogen, Mr. Dentzer also held various positions at Kemper Financial Services and at Bank of America (formerly Bank of Boston). Mr. Dentzer holds a B.A. in philosophy from Boston College and an M.B.A. from the University of Chicago.

公司職務